Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model
Open Biology · 13.05.2026 · 16 (5)
DOI: 10.1098/rsob.250319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Biology, online erschienen am 13.05.2026. Verfasst von Deepthy Francis und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Cambridge , Cambridge, UK. Hauptthemen laut MEDLINE: Kinesins, Neurons, Induced Pluripotent Stem Cells, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Isaac Newton Trust, Biotechnology and Biological Sciences Research Council, Wellcome Trust.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the leading cause of dementia and the most common neurodegenerative disorder. Understanding the molecular pathology of AD may help identify new ways to reduce neuronal damage. In the past decades, Drosophila has become a powerful tool in modelling mechanisms underlying human diseases. Here, we investigate how the expression of the human 42-residue β-amyloid (Aβ) carrying the E22G pathogenic ‘Arctic’ mutation (Aβ42Arc) affects axonal health and behaviour in Drosophila. We find that Aβ42Arc flies present aberrant neurons, with altered axonal transport of mitochondria and aberrant terminal boutons at neuromuscular junctions. We demonstrate that the motor proteins kinesin-1 and kinesin-3 are essential for the correct development of neurons in Drosophila larvae and in human induced pluripotent stem cell-derived cortical neurons. We then show that the overexpression of kinesin-1 or kinesin-3 restores the correct number and morphology of boutons in Aβ42Arc-expressing neurons and rescues neuronal function measured by negative geotaxis locomotor behavioural assay. We therefore provide new evidence towards understanding the mechanisms of axonal transport defects in AD, and our results support the idea that kinesins should be considered as potential drug targets to help reduce dementia-associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Cambridge , Cambridge, UK.
- Gilead Sciences Inc. , Foster City, CA, USA.
- Talisman Therapeutics Ltd , Cambridge, UK.
- University of Auckland - City Campus , Auckland, New Zealand.
- MRC Mitochondrial Biology Unit , Cambridge, UK.
- Royal Society of Chemistry , London, UK.
ORCID-Profile: Victoria L Hewitt, Caroline C G Fabre, Isabel M Palacios
Förderung
- Isaac Newton Trust
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- MRC
- VLH
- European Union
- Paris Region fellowship
- European Commission FP7
Zitieren
APA
Francis, D., Paonessa, F., Hewitt, V. L., Southall, M., Peset, I., Whitworth, A. J., Livesey, F. J., Fabre, C. C. G., & Palacios, I. M. (2026). Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model. Open Biology, 16(5). https://doi.org/10.1098/rsob.250319
Vancouver
Francis D, Paonessa F, Hewitt VL, Southall M, Peset I, Whitworth AJ, et al. Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model. Open Biology. 2026;16(5). doi:10.1098/rsob.250319
BibTeX
@article{Francis2026,
author = {Francis, Deepthy and Paonessa, Francesco and Hewitt, Victoria L and Southall, Maria and Peset, Isabel and Whitworth, Alexander J and Livesey, Frederick J and Fabre, Caroline C G and Palacios, Isabel M},
title = {Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model},
journal = {Open Biology},
year = {2026},
volume = {16},
number = {5},
doi = {10.1098/rsob.250319}
}
EUVIMED